Growth hormone induces interferon gamma production and may play a role in the presentation of alloantigens in vitro

被引:5
作者
Benfield, MR
Vail, A
Bucy, RP
Weigent, DA
机构
[1] UNIV ALABAMA, DEPT PATHOL, BIRMINGHAM, AL 35233 USA
[2] UNIV ALABAMA, DEPT PHYSIOL & BIOPHYS, BIRMINGHAM, AL 35233 USA
关键词
growth hormone; interferon-gamma; mixed leukocyte culture alloantigen; proliferation; cytotoxicity;
D O I
10.1159/000097311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several reports support the view that growth hormone (GH) promotes proliferation and cytotoxicity by T cells in a mixed leukocyte culture (MLC). The present study was undertaken to begin to determine the mechanism of action of GH on the MLC in vitro. First, we determined that peripheral blood mononuclear cells (PBMC) cultured with mitomycin-treated allogeneic PBMC in an MLC in the presence of exogenously added rhGH develop an augmented proliferative (25-100%) and cytotoxic response (50-600%). We next examined the possibility that GH may promote alloresponses by inducing gamma-interferon (IFN gamma) production. In these experiments, in situ hybridization was used to determine the frequency of cells expressing mRNA for IFN gamma. It was observed that GH increased significantly the frequency of cells expressing mRNA for IFN gamma (100-800%). To determine the site of action of rhGH, we evaluated the response of purified T cells to alloantigens in the presence of rhGH. The addition of rhGH to an MLC had no demonstrable effect when purified T cells were used as the responding population. However, when T cells were reconstituted with autologous mitomycin-treated PBMC and used as the responding population, rhGH augmented proliferation and cytotoxicity. Taken together, these data show that rhGH augments proliferation, cytotoxicity and IFN gamma production during an MLC, and at least part of the action of rhGH appears to be on the autologous antigen-presenting cell.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 39 条
[1]  
AHMANN GB, 1981, J IMMUNOL, V127, P2308
[2]   EFFECTS OF GROWTH-HORMONE ADMINISTRATION IN PEDIATRIC RENAL-ALLOGRAFT RECIPIENTS [J].
BARTOSH, S ;
KAISER, B ;
REZVANI, I ;
POLINSKY, M ;
SCHULMAN, S ;
PALMER, JA ;
BALUARTE, HJ .
PEDIATRIC NEPHROLOGY, 1992, 6 (01) :68-73
[3]   GROWTH-HORMONE HETEROGENEITY - GENES, ISOHORMONES, VARIANTS, AND BINDING-PROTEINS [J].
BAUMANN, G .
ENDOCRINE REVIEWS, 1991, 12 (04) :424-449
[4]   TREATMENT OF GROWTH FAILURE IN CHILDREN AFTER RENAL-TRANSPLANTATION [J].
BENFIELD, MR ;
PARKER, KL ;
WALDO, FB ;
OVERSTREET, SL ;
KOHAUT, EC .
TRANSPLANTATION, 1993, 55 (02) :305-308
[5]  
BENFIELD MR, 1994, TRANSPL P, V26, P84
[6]  
BENFIELD MR, 1993, KIDNEY INT, V44, pS62
[7]   ARE MHC CLASS II-RESTRICTED CYTOTOXIC LYMPHOCYTES-T IMPORTANT [J].
BRAAKMAN, E ;
ROTTEVEEL, FTM ;
VANBLEEK, G ;
VANSEVENTER, GA ;
LUCAS, CJ .
IMMUNOLOGY TODAY, 1987, 8 (09) :265-267
[8]   HETEROGENEITY OF SINGLE-CELL CYTOKINE GENE-EXPRESSION IN CLONAL T-CELL POPULATIONS [J].
BUCY, RP ;
PANOSKALTSISMORTARI, A ;
HUANG, GQ ;
LI, JM ;
KARR, L ;
ROSS, M ;
RUSSELL, JH ;
MURPHY, KM ;
WEAVER, CT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1251-1262
[9]  
CESARIO TC, 1994, P SOC EXP BIOL MED, V205, P89
[10]  
DANZER SG, 1994, TRANSPLANTATION, V57, P1638